BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38561018)

  • 1. Trends in Colorectal Cancer Screening from the National Health Interview Survey: Analysis of the Impact of Different Modalities on Overall Screening Rates.
    Ebner DW; Finney Rutten LJ; Miller-Wilson LA; Markwat N; Vahdat V; Ozbay AB; Limburg PJ
    Cancer Prev Res (Phila); 2024 Jun; 17(6):275-280. PubMed ID: 38561018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes.
    Fendrick AM; Fisher DA; Saoud L; Ozbay AB; Karlitz JJ; Limburg PJ
    Cancer Prev Res (Phila); 2021 Sep; 14(9):845-850. PubMed ID: 34021023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Survey of Patient Factors Associated with Colorectal Cancer Screening Preferences.
    Zhu X; Parks PD; Weiser E; Fischer K; Griffin JM; Limburg PJ; Finney Rutten LJ
    Cancer Prev Res (Phila); 2021 May; 14(5):603-614. PubMed ID: 33888515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
    Prince M; Lester L; Chiniwala R; Berger B
    World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPV and Detection Rate of mt-sDNA Testing, FIT, and CT Colonography for Advanced Neoplasia: A Hierarchic Bayesian Meta-Analysis of the Noninvasive Colorectal Screening Tests.
    Pickhardt PJ; Correale L; Hassan C
    AJR Am J Roentgenol; 2021 Oct; 217(4):817-830. PubMed ID: 33703913
    [No Abstract]   [Full Text] [Related]  

  • 6. Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening.
    Finney Rutten LJ; Jacobson RM; Wilson PM; Jacobson DJ; Fan C; Kisiel JB; Sweetser S; Tulledge-Scheitel SM; St Sauver JL
    Mayo Clin Proc; 2017 May; 92(5):726-733. PubMed ID: 28473037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.
    Engel-Nitz NM; Miller-Wilson LA; Le L; Fisher DA
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):843-852. PubMed ID: 37462667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk.
    Fisher DA; Princic N; Miller-Wilson LA; Wilson K; Fendrick AM; Limburg P
    JAMA Netw Open; 2021 Sep; 4(9):e2122269. PubMed ID: 34473259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey.
    Shapiro JA; Klabunde CN; Thompson TD; Nadel MR; Seeff LC; White A
    Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):895-904. PubMed ID: 22490320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Performance of Multitarget Stool DNA and CT Colonography for Noninvasive Colorectal Cancer Screening.
    Pickhardt PJ; Graffy PM; Weigman B; Deiss-Yehiely N; Hassan C; Weiss JM
    Radiology; 2020 Oct; 297(1):120-129. PubMed ID: 32779997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
    Ladabaum U; Mannalithara A
    Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People.
    Redwood DG; Asay ED; Blake ID; Sacco PE; Christensen CM; Sacco FD; Tiesinga JJ; Devens ME; Alberts SR; Mahoney DW; Yab TC; Foote PH; Smyrk TC; Provost EM; Ahlquist DA
    Mayo Clin Proc; 2016 Jan; 91(1):61-70. PubMed ID: 26520415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in colorectal cancer test use among vulnerable populations in the United States.
    Klabunde CN; Cronin KA; Breen N; Waldron WR; Ambs AH; Nadel MR
    Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1611-21. PubMed ID: 21653643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of High-Risk Sessile Serrated Lesions: Multitarget Stool DNA Versus CT Colonography.
    Deiss-Yehiely N; Graffy PM; Weigman B; Hassan C; Matkowskyj KA; Pickhardt PJ; Weiss JM
    AJR Am J Roentgenol; 2022 Apr; 218(4):670-676. PubMed ID: 34755523
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantified trends in provider reimbursement and utilization volume in colorectal cancer screenings: analysis of Medicare claims from 2000 to 2019.
    Bommineni VM; Bommineni VL; Gupta R
    Colorectal Dis; 2024 May; 26(5):1028-1037. PubMed ID: 38581083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline.
    Helsingen LM; Vandvik PO; Jodal HC; Agoritsas T; Lytvyn L; Anderson JC; Auer R; Murphy SB; Almadi MA; Corley DA; Quinlan C; Fuchs JM; McKinnon A; Qaseem A; Heen AF; Siemieniuk RAC; Kalager M; Usher-Smith JA; Lansdorp-Vogelaar I; Bretthauer M; Guyatt G
    BMJ; 2019 Oct; 367():l5515. PubMed ID: 31578196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People.
    Redwood DG; Dinh TA; Kisiel JB; Borah BJ; Moriarty JP; Provost EM; Sacco FD; Tiesinga JJ; Ahlquist DA
    Mayo Clin Proc; 2021 May; 96(5):1203-1217. PubMed ID: 33840520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening.
    Redwood DG; Blake ID; Provost EM; Kisiel JB; Sacco FD; Ahlquist DA
    J Prim Care Community Health; 2019; 10():2150132719884295. PubMed ID: 31646933
    [No Abstract]   [Full Text] [Related]  

  • 20. Colorectal cancer screening uptake and adherence by modality at a large tertiary care center in the United States: a retrospective analysis.
    Cheney C; Parish A; Niedzwiecki D; Oko C; Walters C; Halpern D; Helmueller L; Hoyek NE; Miller-Wilson LA; Sullivan BA
    Curr Med Res Opin; 2024 Mar; 40(3):431-439. PubMed ID: 38197407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.